Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 2, 1997, Pages 279-281

  López Brea, Manuel ^a   Domingo, Diego ^a   Sanchez, Isabel ^a   Alarcon, Teresa ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; EVOLUTION; HELICOBACTER PYLORI; NONHUMAN; SPAIN;

ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTITRICHOMONAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; SPAIN; TETRACYCLINE;

EID: 0041005224     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.2.279     Document Type: Article

References (10)

1. Blaser, M. J. (1992). Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102, 720-7.
2. Labenz, J. & O'Morain, C. (1995). Eradication. Current Opinion on Gastroenterology 11, Suppl. 1, 47-51.
3. National Committee for Clinical Laboratory Standards. (1995). Methods for Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically - Approved Standard M100-S6. NCCLS, Villanova, PA.
4. Westblom, T. U. & Unge, P. (1992). Drug resistance of Helicobacter pylori: memorandum from a meeting at the Sixth International Workshop on Campylobacter, Helicobacter and Related Organisms. Journal of Infectious Diseases 165, 974-5.
5. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. (1992). Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. European Journal of Clinical Microbiology and Infectious Diseases 11, 777-81.
6. Noach, L. A., Langenberg, W. L., Bertola, M. A., Dankert, J. & Tytgat, G. N. (1994). Impact of metronidazole resistance on eradication of Helicobacter pylori. Scandinavian Journal of Infectious Diseases 26, 321-7.
7. López-Brea, M., Martín, E., López-Lavid, C. & Sanz, J. C. (1991). Susceptibility of Helicobacter pylori to metronidazole. European Journal of Clinical Microbiology and Infectious Diseases 10, 1082-3.
8. Glupczynski, Y., Goutier, S., Van den Borre, C., Butzler, J. P. & Burette, A. (1995). Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium from 1989 to 1994. Gut 37, Suppl. 1, A56.
9. Banatvala, N., Davies, G. R., Abdi, Y., Clements, L., Rampton, D. S., Hardie, J. M., Feldman, R. A. et al. (1994). High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35, 1562-6.
10. Xia, H. X., Buckley, M., Keane, C. T. & O'Morain, C. A. (1996). Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. Journal of Antimicrobial Chemotherapy 37, 473-81.